Selected research
Industry Research
Romidepsin Industry Research Report 2026
Market perspective
The global Romidepsin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Romidepsin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Romidepsin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Romidepsin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Romidepsin include Santa Cruz Biotechnology, Inc., Shanghai Rechem science Co., Ltd., Shanghai lollane biological technology Co.,Ltd., Ningbo Inno Pharmchem Co., Ltd., Merck Group, Dalian Meilun Biotech Co., Ltd., TargetMol Chemicals Inc, Selleck Chemicals and InvivoChem LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Romidepsin market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Romidepsin Market by Company
Santa Cruz Biotechnology, Inc.
Shanghai Rechem science Co., Ltd.
Shanghai lollane biological technology Co.,Ltd.
Ningbo Inno Pharmchem Co., Ltd.
Merck Group
Dalian Meilun Biotech Co., Ltd.
TargetMol Chemicals Inc
Selleck Chemicals
InvivoChem LLC
Cckinase, Inc.
Cayman Chemical Company
BPS Bioscience, Inc.
Apexbio Technology LLC
AdooQ BioScience
Romidepsin Segment by Type
0.98
>98%
Romidepsin Segment by Application
Biological
Medical
Romidepsin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Romidepsin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Romidepsin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Romidepsin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Romidepsin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Romidepsin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Romidepsin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.98
- >98%
Applications
- Biological
- Medical
Companies covered
- Santa Cruz Biotechnology, Inc.
- Shanghai Rechem science Co., Ltd.
- Shanghai lollane biological technology Co.,Ltd.
- Ningbo Inno Pharmchem Co., Ltd.
- Merck Group
- Dalian Meilun Biotech Co., Ltd.
- TargetMol Chemicals Inc
- Selleck Chemicals
- InvivoChem LLC
- Cckinase, Inc.
- Cayman Chemical Company
- BPS Bioscience, Inc.
- Apexbio Technology LLC
- AdooQ BioScience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Romidepsin Market Size (2021-2032)
- 2.2.2 Global Romidepsin Sales (2021-2032)
- 2.2.3 Global Romidepsin Market Average Price (2021-2032)
- 2.3 Romidepsin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.98
- 2.3.3 >98%
- 2.4 Romidepsin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Biological
- 2.4.3 Medical
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Romidepsin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Romidepsin Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Romidepsin Revenue of Manufacturers (2021-2026)
- 3.4 Global Romidepsin Average Price by Manufacturers (2021-2026)
- 3.5 Global Romidepsin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Romidepsin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Romidepsin, Product Type & Application
- 3.8 Global Manufacturers of Romidepsin, Established Date
- 3.9 Global Romidepsin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Santa Cruz Biotechnology, Inc.
- 4.1.1 Santa Cruz Biotechnology, Inc. Company Information
- 4.1.2 Santa Cruz Biotechnology, Inc. Business Overview
- 4.1.3 Santa Cruz Biotechnology, Inc. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Santa Cruz Biotechnology, Inc. Romidepsin Product Portfolio
- 4.1.5 Santa Cruz Biotechnology, Inc. Recent Developments
- 4.2 Shanghai Rechem science Co., Ltd.
- 4.2.1 Shanghai Rechem science Co., Ltd. Company Information
- 4.2.2 Shanghai Rechem science Co., Ltd. Business Overview
- 4.2.3 Shanghai Rechem science Co., Ltd. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Rechem science Co., Ltd. Romidepsin Product Portfolio
- 4.2.5 Shanghai Rechem science Co., Ltd. Recent Developments
- 4.3 Shanghai lollane biological technology Co.,Ltd.
- 4.3.1 Shanghai lollane biological technology Co.,Ltd. Company Information
- 4.3.2 Shanghai lollane biological technology Co.,Ltd. Business Overview
- 4.3.3 Shanghai lollane biological technology Co.,Ltd. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai lollane biological technology Co.,Ltd. Romidepsin Product Portfolio
- 4.3.5 Shanghai lollane biological technology Co.,Ltd. Recent Developments
- 4.4 Ningbo Inno Pharmchem Co., Ltd.
- 4.4.1 Ningbo Inno Pharmchem Co., Ltd. Company Information
- 4.4.2 Ningbo Inno Pharmchem Co., Ltd. Business Overview
- 4.4.3 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Product Portfolio
- 4.4.5 Ningbo Inno Pharmchem Co., Ltd. Recent Developments
- 4.5 Merck Group
- 4.5.1 Merck Group Company Information
- 4.5.2 Merck Group Business Overview
- 4.5.3 Merck Group Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Group Romidepsin Product Portfolio
- 4.5.5 Merck Group Recent Developments
- 4.6 Dalian Meilun Biotech Co., Ltd.
- 4.6.1 Dalian Meilun Biotech Co., Ltd. Company Information
- 4.6.2 Dalian Meilun Biotech Co., Ltd. Business Overview
- 4.6.3 Dalian Meilun Biotech Co., Ltd. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dalian Meilun Biotech Co., Ltd. Romidepsin Product Portfolio
- 4.6.5 Dalian Meilun Biotech Co., Ltd. Recent Developments
- 4.7 TargetMol Chemicals Inc
- 4.7.1 TargetMol Chemicals Inc Company Information
- 4.7.2 TargetMol Chemicals Inc Business Overview
- 4.7.3 TargetMol Chemicals Inc Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 TargetMol Chemicals Inc Romidepsin Product Portfolio
- 4.7.5 TargetMol Chemicals Inc Recent Developments
- 4.8 Selleck Chemicals
- 4.8.1 Selleck Chemicals Company Information
- 4.8.2 Selleck Chemicals Business Overview
- 4.8.3 Selleck Chemicals Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Selleck Chemicals Romidepsin Product Portfolio
- 4.8.5 Selleck Chemicals Recent Developments
- 4.9 InvivoChem LLC
- 4.9.1 InvivoChem LLC Company Information
- 4.9.2 InvivoChem LLC Business Overview
- 4.9.3 InvivoChem LLC Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 InvivoChem LLC Romidepsin Product Portfolio
- 4.9.5 InvivoChem LLC Recent Developments
- 4.10 Cckinase, Inc.
- 4.10.1 Cckinase, Inc. Company Information
- 4.10.2 Cckinase, Inc. Business Overview
- 4.10.3 Cckinase, Inc. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cckinase, Inc. Romidepsin Product Portfolio
- 4.10.5 Cckinase, Inc. Recent Developments
- 4.11 Cayman Chemical Company
- 4.11.1 Cayman Chemical Company Company Information
- 4.11.2 Cayman Chemical Company Business Overview
- 4.11.3 Cayman Chemical Company Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Cayman Chemical Company Romidepsin Product Portfolio
- 4.11.5 Cayman Chemical Company Recent Developments
- 4.12 BPS Bioscience, Inc.
- 4.12.1 BPS Bioscience, Inc. Company Information
- 4.12.2 BPS Bioscience, Inc. Business Overview
- 4.12.3 BPS Bioscience, Inc. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BPS Bioscience, Inc. Romidepsin Product Portfolio
- 4.12.5 BPS Bioscience, Inc. Recent Developments
- 4.13 Apexbio Technology LLC
- 4.13.1 Apexbio Technology LLC Company Information
- 4.13.2 Apexbio Technology LLC Business Overview
- 4.13.3 Apexbio Technology LLC Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Apexbio Technology LLC Romidepsin Product Portfolio
- 4.13.5 Apexbio Technology LLC Recent Developments
- 4.14 AdooQ BioScience
- 4.14.1 AdooQ BioScience Company Information
- 4.14.2 AdooQ BioScience Business Overview
- 4.14.3 AdooQ BioScience Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 AdooQ BioScience Romidepsin Product Portfolio
- 4.14.5 AdooQ BioScience Recent Developments
5 Global Romidepsin Market Scenario by Region
- 5.1 Global Romidepsin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Romidepsin Sales by Region: 2021-2032
- 5.2.1 Global Romidepsin Sales by Region: 2021-2026
- 5.2.2 Global Romidepsin Sales by Region: 2027-2032
- 5.3 Global Romidepsin Revenue by Region: 2021-2032
- 5.3.1 Global Romidepsin Revenue by Region: 2021-2026
- 5.3.2 Global Romidepsin Revenue by Region: 2027-2032
- 5.4 North America Romidepsin Market Facts & Figures by Country
- 5.4.1 North America Romidepsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Romidepsin Sales by Country (2021-2032)
- 5.4.3 North America Romidepsin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Romidepsin Market Facts & Figures by Country
- 5.5.1 Europe Romidepsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Romidepsin Sales by Country (2021-2032)
- 5.5.3 Europe Romidepsin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Romidepsin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Romidepsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Romidepsin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Romidepsin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Romidepsin Market Facts & Figures by Country
- 5.7.1 South America Romidepsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Romidepsin Sales by Country (2021-2032)
- 5.7.3 South America Romidepsin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Romidepsin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Romidepsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Romidepsin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Romidepsin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Romidepsin Sales by Type (2021-2032)
- 6.1.1 Global Romidepsin Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Romidepsin Sales Market Share by Type (2021-2032)
- 6.2 Global Romidepsin Revenue by Type (2021-2032)
- 6.2.1 Global Romidepsin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Romidepsin Revenue Market Share by Type (2021-2032)
- 6.3 Global Romidepsin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Romidepsin Sales by Application (2021-2032)
- 7.1.1 Global Romidepsin Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Romidepsin Sales Market Share by Application (2021-2032)
- 7.2 Global Romidepsin Revenue by Application (2021-2032)
- 7.2.1 Global Romidepsin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Romidepsin Revenue Market Share by Application (2021-2032)
- 7.3 Global Romidepsin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Romidepsin Value Chain Analysis
- 8.1.1 Romidepsin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Romidepsin Production Mode & Process
- 8.2 Romidepsin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Romidepsin Distributors
- 8.2.3 Romidepsin Customers
9 Global Romidepsin Analyzing Market Dynamics
- 9.1 Romidepsin Industry Trends
- 9.2 Romidepsin Industry Drivers
- 9.3 Romidepsin Industry Opportunities and Challenges
- 9.4 Romidepsin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst